Update on Efficacy and Tolerability of Ofatumumab as Front-Line Treatment for Patients with CLL that are Elderly and Have Severe Co-Morbidities and/or Other Malignancies

Elderly individuals with chronic lymphocytic leukemia (CLL) often present with multiple comorbidities and other cancers. Current therapy for these patients is largely based on targeted agents and/or monoclonal antibodies without chemotherapy.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Lorenzo Falchi, Candida Vitale, Maria Ciccone, Christina Hinojosa, Michael Keating, Naveen Pemmaraju, William Wierda, Gautham Borthakur, Jan Burger, Alessandra Ferrajoli Source Type: research